Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ROY F CHEMALY and VICTOR EDUARDO MULANOVICH.
ROY F CHEMALY
Connection Strength
3.292
VICTOR EDUARDO MULANOVICH
  1. Cluster and sporadic cases of herbaspirillum species infections in patients with cancer. Clin Infect Dis. 2015 Jan 01; 60(1):48-54.
    View in: PubMed
    Score: 0.490
  2. Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes. Open Forum Infect Dis. 2024 Aug; 11(8):ofae422.
    View in: PubMed
    Score: 0.242
  3. Implementation of an Automated Antibiotic Time-out at a Comprehensive Cancer Center. Open Forum Infect Dis. 2024 May; 11(5):ofae235.
    View in: PubMed
    Score: 0.239
  4. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer. J Infect Dis. 2023 11 28; 228(11):1549-1558.
    View in: PubMed
    Score: 0.232
  5. Combination of baloxavir and oseltamivir for treatment of severe influenza infection in hematopoietic cell transplant recipients: a novel treatment strategy for a high-risk population. Microbes Infect. 2022 Apr-May; 24(3):104895.
    View in: PubMed
    Score: 0.201
  6. Immune reconstitution and severity of COVID-19 among hematopoietic cell transplant recipients. Transpl Infect Dis. 2021 Aug; 23(4):e13606.
    View in: PubMed
    Score: 0.193
  7. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014. BMC Infect Dis. 2019 Nov 06; 19(1):934.
    View in: PubMed
    Score: 0.175
  8. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int. 2018 06; 31(6):639-648.
    View in: PubMed
    Score: 0.156
  9. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer. 2017 Jun 15; 123(12):2329-2337.
    View in: PubMed
    Score: 0.145
  10. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res. 2016 10; 134:58-62.
    View in: PubMed
    Score: 0.140
  11. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index. Biol Blood Marrow Transplant. 2016 Mar; 22(3):542-8.
    View in: PubMed
    Score: 0.133
  12. Respiratory syncytial virus infections in children with cancer. J Pediatr Hematol Oncol. 2014 Aug; 36(6):e376-81.
    View in: PubMed
    Score: 0.122
  13. Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect. 2014 Oct; 20(10):O672-9.
    View in: PubMed
    Score: 0.118
  14. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2013 Oct; 41(5):1039-40.
    View in: PubMed
    Score: 0.110
  15. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res. 2012; 2(4):203-18.
    View in: PubMed
    Score: 0.108
  16. Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
    View in: PubMed
    Score: 0.105
  17. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
    View in: PubMed
    Score: 0.085
  18. International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship. Elife. 2023 01 30; 12.
    View in: PubMed
    Score: 0.055
  19. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv. 2022 Aug 26.
    View in: PubMed
    Score: 0.053
  20. Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. J Clin Oncol. 2021 08 20; 39(24):2710-2719.
    View in: PubMed
    Score: 0.048
  21. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. Mediterr J Hematol Infect Dis. 2020; 12(1):e2020044.
    View in: PubMed
    Score: 0.046
  22. Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center. Am J Infect Control. 2014 Oct; 42(10):1084-8.
    View in: PubMed
    Score: 0.031
  23. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
    View in: PubMed
    Score: 0.023
  24. Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention. Bone Marrow Transplant. 2010 Feb; 45(2):339-47.
    View in: PubMed
    Score: 0.021
  25. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med. 2009 Mar; 265(3):397-400.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.